Extracorporeal shock wave treatment

06

Dec 2022

In November 2022, the National Institute for Health and Care Excellence (NICE) published five new Interventional Procedure Guidance (extracorporeal shockwave therapy for calcific tendinopathy in the shoulder, balloon disimpaction of the baby's head at emergency cesarean, percutaneous ultrasound-guided microwave ablation for benign thyroid nodules, ab interno canaloplasty for open-angle glaucoma, tunnelled peritoneal drainage catheter insertion), and two new Medical Technologies Guidance (GreenLight XPS, Optilume). Also, one new clinical guideline was published, and one was updated. Read more

07

May 2018

On the 19th of April of 2018, the Federal Joint Committee (G-BA) was able to reassess previously excluded use of extracorporeal shockwave therapy (ESWT) in the indication of heel pain in plantar fasciitis on a current scientific basis and decided that ESWT will be used in out-patient settings in the future. Read more

14

Jun 2017

Recently the Institute for Quality and Efficiency in Health Care (IQWIG) published final report of evaluation extracorporeal shock wave therapy in patients with heel pain. On 31st of May, the Federal Joint Committee (G-BA) requested manufacturers for notification of their devices for extracorporeal shock wave therapy before final decision will be given. Read more

30

May 2017

The Institute for Quality and Efficiency in Health Care (IQWIG) published final report of evaluation of extracorporeal shock wave therapy in patients with heel. Results demonstrated benefit of the extracorporeal treatment in comparison with placebo, ultrasound and iontophoresis. Read more